1Ambrosini G, Adida C, Altieri D C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med, 1997, 3:917-921.
2Gleason D F. Histologic grading of prostate cancer: a perspective. Hum Pathol, 1992, 23:273-275.
3夏同礼主编.前列腺的基础与临床.北京:北京科学出版社,2000.206-207.
4Turner H E, Nagy Z, Gatter K C, et al. Proliferation,bcl-2 expression and angiogenesis in piyuitary adenomas: relationship to tumor behaviour. Br J Cancer,2000, 82:1441-1445.
5Kawasaki H, Toyoda M, Shinohara H, et al. Expression of survivin correlated with apoptosis, proliferation,and angiogenesis during human colorectal tumorigenesis. Cancer, 2001, 91:2026-2032.
2Athanassiadou P, Bantis A, Gonidi M,et al. The expression of metallothioneins on imprint smears of prostate carcinoma : correlation with clinicopathologic parameters and tumor proliferative capacity [J]. Tumori ,2007,93 (2): 189-194.
3Santinelli A, Mazzucchelli R, Barbisan F, et al. alpha-Methylacyl coenzyme A racemase, Ki-67, and topoisomerase II alpha in cystoprostatectomies with incidental prostate cancer [ J ]. Am J Clin Pathol,2007,128(4) :657-666.
4Halvorsen OJ, Haukaa S, Hoisaeter PA, et al. Maximum Ki-67 staining in prostate cancer provides indepent prognostic information after radical prostatectomy [ J ]. Anticancer Res, 2001,21 ( 6A ) : 4071-4076.
5Li R,Heydon K,Hammond ME,et al. Ki-67 staining index predicts distant metastasis and survival in locally advanced prostate cancer treated with radiotherapy [ J ]. Clin Cancer Res,2004,10 ( 12 Pt 1 ) : 4118-4124.
6Laitinen S, Martikainen PM, Tolonen T, et al. EZH2, Ki-67 and MCM7 are prognostic markers in prostatectomy treated patients [J]. Int J Cancer,2008,122(3) :595-602.
7Rubio J, Ramos D, Lopez-Guemen GA, et al. Immunohistochemieal expression of Ki-67 antigen, cox-2 and Bax/Bcl-2 in prostate cancer; prognostic value in biopsies and radical prostatectomy specimens[ J]. Eur Urol,2005,48 (5) :745-751.
8Bantis A, Giannopoulos J, Gonidi M,et al. Expression of P120, Ki- 67 and PCNA as proliferation biomarkers in imprint smears of prostate carcinoma and their prognosticsmears of prostate carcinoma and their prognostic value[ J]. Cytopathology,2004,15 ( 1 ) :25-31.
9Akhavan A, McHugh KH, Guruli G, et al. Endothelin receptor A blockade enhances taxane effects in prostate cancer[ J ]. Neoplasia, 2006,8(9) :725-732.
10Kausch I, Lingnau A, Endl E, et al. Antisense treatment against KI- 67 Mma inhibits proliferation and tumor growth in vitro and in vivo [ J ]. Int J Cancer,2003,105 (5) :710-716.
